

NeuroscienceThe Neuroscience group focuses on understanding fundamental neurobiological mechanisms in health and disease and the identification of new treatments. Emphasis is placed upon schizophrenia, Parkinson’s disease, stroke, cognitive and hearing disorders. Research activities span multiple levels – from genetics, molecules, cells, circuits and neural systems through to pharmacology, behaviour and cognition and incorporate a wide array of techniques from genomics, transcriptomics, and metabolomics to brain imaging, biophotonics, electrophysiology, stem cell manipulation, behaviour, and the development of a range of in vivo models including transgenic mice. Several projects are integrated with human research in terms of drug discovery, diagnostics and genetic vulnerability. Staff involvedDr Ros Brett, Dr Trevor Bushell [neuroscience, cellular neurophysiology, neuropharmacology], Dr Hilary Carswell, Dr John Connolly, Dr John Dempster, Dr Ben Pickard, Professor Judith Pratt, Dr Shuzo Sakata, Professor Philip Winn. Postgraduate Research OpportunitiesState-dependent synchrony propagation in neural circuitsProteinase-activated receptor 2 (PAR2) as a target for the treatment of inflammation-related CNS disorders Proteinase-activated receptor 2 (PAR2): Are astrocytes responsible for PAR2-mediated actions within the CNS? Cannabidiol: a constituent of cannabis with psychoactive properties? Understanding Schizophrenia: From genes to neural systems to drug discovery Treating Parkinson’s disease Understanding the addictive properties of nicotine Circuit analysis of auditory perception |